Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection (RIPI)
Status
Conditions
Details and patient eligibility
About
As Covid 19 manifestations that have been recently described, inflammatory manifestation have major impact in infectious disease lesions. Some of them are delayed and provide Post infectious inflammatory reaction (PIIR), they are challenging for diagnosis and for management. Clinician have to avoid unnecessary antibiotic thearapy and in if necessary have to give immunosuppressive therapy. Except for rheumatic disease for group A streptococcus (GAS) infections there are not stanrdized diagnostic criteria and therapeutic protocol, and PIIR have probably a suboptimal management. In this context the investigators aim to explore PIIR in the 3 most frequent bacterial invasive infection in France, by a retrospective monocentric study. The investigators include all children betwwen 2012 and 2018 hospitalized for infections by Streptococcus pneumoniae (SP), Neisseria meningitidis (NM), and GAS invasive infections.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Less than 18 years of age
- Fever associated with GAS, NM, or SP invasive infection
Exclusion criteria
- age > 18 years
- Impossibility to obtain the consent of parents / legal representatives.
Trial contacts and locations
Loading...
Central trial contact
Eric JEZIORSKI
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal